Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1976 Aug;34(2):174–179. doi: 10.1038/bjc.1976.140

Clinical trial of combination chemotherapy and specific active immunotherapy in disseminated melanoma.

E S Newlands, C J Oon, J T Roberts, P Elliott, R F Mould, C Topham, F J Madden, K A Newton, G Westbury
PMCID: PMC2025153  PMID: 962994

Abstract

Fifty-six patients with disseminated malignant melanoma were randomly allocated to two treatment groups. The first group C received combination chemotherapy consisting of DTIC and ICRF 159. The second group (C+I) received the same chemotherapy but were also immunized with 2 X 10(7) irradiated allogeneic melanoma cells mixed with 50 mug of percutaneous BCG. The survival rates in both treatment groups C and (C+I) were not significantly different, and only minor enhancement of the chemotherapy was found in the (C+I) group. A similar pattern of tissue response was observed in both groups: lymph node, skin and, to some extent liver metastases, respond better than other sites.

Full text

PDF
174

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butterworth C., Oon C. J., Westbury G., Hobbs J. R. T-lymphocyte responses in patients with malignant melanoma. Eur J Cancer. 1974 Oct;10(10):639–646. doi: 10.1016/0014-2964(74)90002-4. [DOI] [PubMed] [Google Scholar]
  2. Comis R. L., Carter S. K. Integration of chemotherapy into combined modality therapy of solid tumors. IV. Malignant melanoma. Cancer Treat Rev. 1974 Dec;1(4):285–304. doi: 10.1016/s0305-7372(74)80020-4. [DOI] [PubMed] [Google Scholar]
  3. Currie G. A. Active immunotherapy with Corynebacterium parvum and chemotherapy in murine fibrosarcomas. Br Med J. 1970 Feb 28;1(5695):541–544. doi: 10.1136/bmj.1.5695.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Currie G. A., Lejeune F., Fairley G. H. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma. Br Med J. 1971 May 8;2(5757):305–310. doi: 10.1136/bmj.2.5757.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Currie G. A., McElwain T. J. Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study. Br J Cancer. 1975 Feb;31(2):143–156. doi: 10.1038/bjc.1975.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Einhorn L. H., Burgess M. A., Vallejos C., Bodey G. P., Sr, Gutterman J., Mavligit G., Hersh E. M., Luce J. K., Frei E., 3rd, Freireich E. J. Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res. 1974 Aug;34(8):1995–2004. [PubMed] [Google Scholar]
  7. Gutterman J. U., Mavligit G., Gottlieb J. A., Burgess M. A., McBride C. E., Einhorn L., Freireich E. J., Hersh E. M. Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and bacillus calmette--guérin. N Engl J Med. 1974 Sep 19;291(12):592–597. doi: 10.1056/NEJM197409192911202. [DOI] [PubMed] [Google Scholar]
  8. Gutterman J. U., Mavligit G., McBride C., Frei E., 3rd, Freireich E. J., Hersh E. M. Active immunotherapy with B.C.G. for recurrent malignant melanoma. Lancet. 1973 Jun 2;1(7814):1208–1212. doi: 10.1016/s0140-6736(73)90526-6. [DOI] [PubMed] [Google Scholar]
  9. Ikonopisov R. L., Lewis M. G., Hunter-Craig I. D., Bodenham D. C., Phillips T. M., Cooling C. I., Proctor J., Fairley G. H., Alexander P. Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J. 1970 Jun 27;2(5712):752–754. doi: 10.1136/bmj.2.5712.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Johnson F. D., Jacobs E. M. Chemotherapy of metastatic malignant melanoma. Experience with 73 patients. Cancer. 1971 Jun;27(6):1306–1312. doi: 10.1002/1097-0142(197106)27:6<1306::aid-cncr2820270605>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  11. Luce J. K. Chemotherapy of malignant melanoma. Cancer. 1972 Dec;30(6):1604–1615. doi: 10.1002/1097-0142(197212)30:6<1604::aid-cncr2820300629>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  12. Mould R. F. Calculation of survival rates by the life table and other methods. Clin Radiol. 1976 Jan;27(1):33–38. doi: 10.1016/s0009-9260(76)80011-6. [DOI] [PubMed] [Google Scholar]
  13. Wagner D. E., Ramirez G., Weiss A. J., Hill G., Jr Combination phase 1-II study of imidazole carboxamide (NCS45388). Oncology. 1972;26(2):310–316. doi: 10.1159/000224680. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES